For the better part of ten years NORML (and the ACLU’s Drug Litigation Project) have been 1) monitoring increasing numbers of medical patients denied access to organ transplants for the singular reason that they test positive for cannabis and 2) researching litigation and legislative options to compel organ banks to stop discriminating against medical patients who use cannabis, most especially in states where medical marijuana patients are supposed to be protected by state laws.
A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.
Investigators discover time after time that it works!
Below is this week’s summary of pending legislation and tips to help you become involved…
Below is this week’s summary of pending state legislation and tips to help you become…
Most recently, a Canadian research team took the time to actually interview various cannabis consumers.
According to the latest statistics from the US Department of Health and Human Services, a startling high number of US government-defined marijuana ‘addicts’ don’t even smoke pot! That’s right, according to a recent DHS report, more than one-third of Americans entered into drug treatment with a primary diagnosis of marijuana ‘dependency’ haven’t used pot in the month prior to their admission.